SpringerLink
Log in

Dacarbazine/nivolumab

Drug eruption and nausea: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Saito R, et al. Case of malignant melanoma responding to dacarbazine following nivolumab. Dermatologic Therapy 32: e12791, No. 2, Mar-Apr 2019. Available from: URL: http://doi.org/10.1111/dth.12791 - Japan

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dacarbazine/nivolumab. Reactions Weekly 1751, 120 (2019). https://doi.org/10.1007/s40278-019-61253-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-61253-4

Search

Navigation